Sector
PharmaceuticalsOpen
₹29.4Prev. Close
₹28Turnover(Lac.)
₹2.57Day's High
₹29.4Day's Low
₹28.0652 Week's High
₹62.7552 Week's Low
₹21.03Book Value
₹51.16Face Value
₹10Mkt Cap (₹ Cr.)
37.88P/E
0EPS
0Divi. Yield
018 Sep 2024
12:00 AM
AGM
Announcement Date: 18 Sep, 2024
22 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 13.42 | 17.75 | 15.06 | 6.63 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 63.65 | 67.79 | 68.42 | 34.72 |
Net Worth | 77.07 | 85.54 | 83.48 | 41.35 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 154.37 | 126.83 | 121.69 | 76.04 |
yoy growth (%) | 21.72 | 4.21 | 60.03 | 12.37 |
Raw materials | -103.96 | -88.96 | -87.84 | -52.89 |
As % of sales | 67.34 | 70.14 | 72.17 | 69.55 |
Employee costs | -13.67 | -7.93 | -6.39 | -5.64 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 10.13 | 8.4 | 8.1 | 4.95 |
Depreciation | -1.31 | -1.22 | -1.12 | -1.19 |
Tax paid | -3.11 | -2.31 | -2.45 | -1.22 |
Working capital | 19.15 | 4.18 | 12.01 | 8.57 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 21.72 | 4.21 | 60.03 | 12.37 |
Op profit growth | 14.75 | 6.52 | 61.15 | 12.43 |
EBIT growth | 16.24 | 7.86 | 59.96 | 22.36 |
Net profit growth | 15.28 | 7.9 | 51.68 | 31.89 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 92.85 | 146.11 | 219.89 | 354.3 | 154.38 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 92.85 | 146.11 | 219.89 | 354.3 | 154.38 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.01 | 0.7 | 9.72 | 0.9 | 0.56 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,676.8 | 93.94 | 4,02,320.49 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,811.45 | 81.86 | 1,80,822.6 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,505.3 | 25.26 | 1,21,584.26 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,409.7 | 60.56 | 1,15,394.56 | 474 | 0.94 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,283.7 | 20.03 | 1,07,135.26 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rajesh Gupta
Whole Time Director & CFO
Saruchi Gupta
Independent Director
Sukhpal Singh
Independent Director
Chetna
Company Sec. & Compli. Officer
Harshita Aggarwal
Non Executive Director
Rohit Mittal
Independent Director
Harvinder Singh Dhami
Darbara Complex SCO 113 I Flr,
Dist. Shopping Centre B Block,
Punjab - 143001
Tel: 91-0183-5070118/5070119
Website: http://www.anglifesciences.com
Email: cs@anglifesciences.com
E-2/3 Ansa Indl Est,
Saki Vihar Road, Sakinaka Andheri(E),
Mumbai - 400072
Tel: 91-22-40430200/28470
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company...
Read More
Reports by ANG Lifesciences India Ltd
What is the ANG Lifesciences India Ltd share price today?
What is the Market Cap of ANG Lifesciences India Ltd?
What is the PE and PB ratio of ANG Lifesciences India Ltd?
What is the 52 Week High and Low of ANG Lifesciences India Ltd?
What is the CAGR of ANG Lifesciences India Ltd?
What is the shareholding pattern of ANG Lifesciences India Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.